Reducing Risks of Adverse Events from New Drugs in Older Australians
Author Information
Author(s): Margaret T Whitstock, Christopher M Pearce, Stephen C Ridout, Elizabeth J Eckermann
Primary Institution: Deakin University
Hypothesis
Can clinical trial data combined with administrative health data help identify older patients at risk of adverse drug events from newly released medications?
Conclusion
The study found that combining clinical trial data with health records can help identify older patients at risk of adverse events from new drugs, potentially reducing harm.
Supporting Evidence
- One in ten Australian patients has experienced an adverse drug event in the past six months.
- 68.8% of patients aged 65 and over prescribed arthritis medications were also prescribed cardiovascular drugs.
- Older patients are particularly vulnerable to adverse drug events due to multiple medications and age-related changes.
Takeaway
This study shows that by looking at health data, we can find out which older people might get hurt by new medicines, helping doctors make safer choices.
Methodology
The study analyzed clinical trial data and linked health records to identify comorbidities and co-medications in older patients who might be at risk when prescribed new drugs.
Potential Biases
Potential bias due to reliance on available clinical trial data which may not represent the broader population.
Limitations
The study primarily focused on one drug and may not generalize to all newly released medications.
Participant Demographics
Older Australians aged 65 years and over, with a focus on those with arthritis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website